Global X Scientific Beta Japan
ALTAR
Score™
6.8% info Recommen-
dation
NEUTRAL
2019E    2020E
P/E
ratio
15.1x P/Sales
ratio
0.6x
P/BV
ratio
1.1x Div.
yield
2.5%


  • Description
  • Performance
  • Comps
  • premium Fundamentals
  • premium Valuation
  • premium Rating
Global X Scientific Beta Japan ETF is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond generally to the price and yield performance, before fees and expenses, of the Scientific Beta Japan Multi-Beta Multi-Strategy Equal Risk Contribution Index.

FUND BASICS
Category International Equities
Fund Sponsor Global X Management Co LLC
Website www.globalxfunds.com
Inception date May 13, 2015
Assets (mns) $3
Currency USD
Expense ratio 39 bp
Distributions Annually

FUND STRUCTURE
Regulation Open-End Investment Company
Custodian Brown Brothers Harriman & Co
Weighting Multi-Factor
Index replication Full
Uses derivatives No
Options available No

SECTOR BREAKDOWN

 


CONSTITUENT BREAKDOWN
No. of constituents 226
Wgt avg mkt cap (mns) $14,828
Large cap (>$10bn) 40.0%
Mid cap ($2-10bn) 59.8%
Small cap (<$2bn) 0.2%
Developed mkts 100.0%
Emerging mkts 0.0%

TOP TEN HOLDINGS
FUJITSU LTD 1.2 %
NEC CORP 1.1 %
JAPAN POST HOLDINGS CO. LTD. 1.0 %
JAPAN RETAIL FUND INVESTMENT 1.0 %
NIPPON TELEGRAPH AND TELEPHONE COR 1.0 %
RICOH CO LTD 1.0 %
CHUGOKU ELECTRIC POWER CO 1.0 %
NIPPON MEAT PACKERS INC 1.0 %
MITSUBISHI TANABE PHARMA 0.9 %
TOYO SUISAN KAISHA LTD 0.9 %
Total 10.1 %

TOP COUNTRY EXPOSURE
JAPAN 99.2 %










HISTORICAL PERFORMANCE info

  Custom date range Compare to  
  thru


Standardized Annual Returns (thru November 30)
Year-to-date 1 year 5 years 10 years Since Incep.
11.5% 3.9% -- -- 5.5%

Market Correlations
versus... Beta R-squared
S&P500 0.71 59%
MSCI EAFE 0.86 73%
MSCI Emg. Mkts. 0.64 63%

Technical Indicators
Recent close $28.88
30d moving avg. $28.56
Annualized volatility 11.1%
Short interest (ETF) 1.0%
Relative strength (RSI) 66

Liquidity measures
Avg. volume (thou.) 0
Turnover 0.0%
Bid/Ask (% of price) 0.32%
ADV underlying (mns) $9,668

Distributions


FINDING ALTERNATIVE FUNDS

Below is a list of 20 potential alternatives to the Global X Scientific Beta Japan ETF based on the alternatives' overlap in portfolio holdings with SCIJ. Consider funds with lower expense ratios and/or higher ALTAR Score™ ratings as possible alternatives.

Benchmark ticker: SCIJ Expense: 39 bp ALTAR Score™: 6.8%


ALTERNATIVE ETFs BASED ON OVERLAP WITH SCIJ
Ticker Fund
Name
Overlap1
vs SCIJ
(%)
Expense
ratio
(bp)
Savings
vs SCIJ
(bp)
ALTAR
Score™
(%)
ALTAR
vs SCIJ
(%)
EWJE iShares MSCI Japan Equal Weighted 58.0 15 24 7.2 +0.3
JPMV iShares MSCI Japan Min Volatility 49.3 30 9 6.6 -0.2
GSJY Goldman Sachs ActiveBeta Japan Equity 48.7 25 14 7.6 +0.7
BBJP JPMorgan BetaBuilders Japan 45.9 19 20 7.7 +0.9
QJPN SPDR MSCI Japan Quality Mix 45.4 14 25 7.9 +1.0
EWJ iShares MSCI Japan 45.2 47 -8 7.5 +0.7
DBJP Xtrackers MSCI Japan Hedged 44.4 45 -6 7.5 +0.7
HFXJ IQ 50 Percent Hedged FTSE Japan 43.1 30 9 7.7 +0.9
FLJP Franklin FTSE Japan 42.7 9 30 7.9 +1.1
FLJH Franklin FTSE Japan Hedged 42.5 9 30 7.9 +1.1
JPXN iShares JPX-Nikkei 400 41.4 48 -9 7.5 +0.7
JPN Xtrackers Japan JPX-Nikkei 400 Equity 41.2 9 30 7.9 +1.1
EWJV iShares MSCI Japan Value 38.5 15 24 9.9 +3.1
IPAC iShares Core MSCI Pacific 33.7 9 30 7.4 +0.5
DXJ WisdomTree Japan Hedged Equity 30.9 48 -9 8.5 +1.7
VPL Vanguard Pacific ETF 28.6 9 30 7.7 +0.9
PQIN PGIM QMA Strategic Alpha International Equity 27.0 29 10 7.2 +0.4
RFAP First Trust Riverfront Dynamic Asia Pacific 26.9 83 -44 7.2 +0.4
FJP First Trust Japan AlphaDEX 25.4 80 -41 8.6 +1.8
IVLU iShares MSCI Int'l Developed Value Factor 24.5 30 9 10.2 +3.4

1Overlap is the percentage of holdings by weight that are identical. For example, if Fund A has a 2% position in Apple, Inc. (AAPL) and Fund B has a 5% position, their overlapping position in AAPL is 2%.

Content on this tab for subscribers only**

RESULTS & ESTIMATES

  2014 2015 2016 2017 2018 2019E 2020E
Sales per share ** ** ** ** ** ** **
Earnings per share ** ** ** ** ** ** **
Dividends per share info ** ** ** ** ** ** **
Book value per share ** ** ** ** ** ** **

 

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

Sales per share growth   **% **% **% **% **% **%
EPS growth   **% **% **% **% **% **%

OTHER FUNDAMENTAL METRICS

Long term EPS growth est. **%   Debt-to-equity **x
Asset turnover **%   Assets-to-equity **x

Return on equity

Revision activity*
*Six months ago = 100

Net margins

Compound annual growth rates

Content on this tab for subscribers only

VALUATION METRICS
  2018 2019E 2020E
Price-to-sales ** ** **
Price-to-earnings ** ** **
Price-to-cash flow ** ** **
Price-to-growth ** ** **
Price-to-book value ** ** **
Yield ** ** **

Historical valuation trends

Forward
multiple:
Global X Scientific Beta Japan
Relative
to:
S&P500 MSCI EAFE MSCI Emg. Mkts. Other ETF:

NEUTRAL

Average appreciation potential. A rating of NEUTRAL is assigned to ETFs with ALTAR Scores in the middle quintile (ranking between 40%-60%) of their category. This indicates that valuations adequately reflect the fundamentals of stocks in these funds.

ALTAR Score™


Calculation of ALTAR Score™
Avg. Return on Equity 7.7 %
Divided by: Fwd. P/BV 1.1 x
Less: Expense ratio 39 bp
Equals: ALTAR Score 6.8 %
info More information on ALTAR Score™

MODERN PORTFOLIO THEORY info

CONSENSUS RECOMMENDATIONS: FUND CONSTITUENTS
COMPOSITE
RATING
1.72 CATEGORY
AVERAGE
1.63
 
The composite rating is a weighted average of analysts' consensus recommendations for individual ETF constituents, based on the following scale:

BUY = 1; OVERWEIGHT = 1.5, HOLD = 2; UNDERWEIGHT = 2.5; and SELL = 3.

Readers are cautioned that because analyst ratings tend to be inflated, the composite score may be more useful as a relative measure of sentiment between funds rather than as a stand-alone recommendation.
 

 

See RATING tab for calculation of ALTAR Score™
Risk & reward. Uses std. dev. as proxy for risk, ALTAR Score™ for return forecast.
Dividends paid by constituents to the fund. May differ from actual distributions to shareholders due to constituent changes, timing issues or other factors.
Monthly returns based on changes in price plus dividends. May differ from daily returns reported by funds. See below for standardized returns.